[1]
F. Saad, F. Pouliot, B. Danielson, C. Catton, and A. Kapoor, “Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidence”, CUAJ, vol. 12, no. 9, pp. E415–20, May 2018.